KVUE vs. ABT
Compare and contrast key facts about Kenvue Inc. (KVUE) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KVUE or ABT.
Correlation
The correlation between KVUE and ABT is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
KVUE vs. ABT - Performance Comparison
Key characteristics
KVUE:
1.01
ABT:
1.37
KVUE:
1.80
ABT:
2.01
KVUE:
1.22
ABT:
1.26
KVUE:
0.85
ABT:
1.10
KVUE:
3.72
ABT:
6.73
KVUE:
7.57%
ABT:
4.18%
KVUE:
27.91%
ABT:
20.59%
KVUE:
-33.22%
ABT:
-45.66%
KVUE:
-8.27%
ABT:
-4.67%
Fundamentals
KVUE:
$45.36B
ABT:
$230.70B
KVUE:
$0.54
ABT:
$7.70
KVUE:
43.78
ABT:
17.22
KVUE:
2.42
ABT:
4.17
KVUE:
2.93
ABT:
5.33
KVUE:
4.69
ABT:
4.69
KVUE:
$11.56B
ABT:
$42.34B
KVUE:
$6.71B
ABT:
$23.67B
KVUE:
$2.36B
ABT:
$10.37B
Returns By Period
In the year-to-date period, KVUE achieves a 11.49% return, which is significantly lower than ABT's 18.80% return.
KVUE
11.49%
5.55%
3.36%
28.41%
N/A
N/A
ABT
18.80%
7.42%
14.14%
28.49%
9.16%
13.00%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
KVUE vs. ABT — Risk-Adjusted Performance Rank
KVUE
ABT
KVUE vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Kenvue Inc. (KVUE) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
KVUE vs. ABT - Dividend Comparison
KVUE's dividend yield for the trailing twelve months is around 3.46%, more than ABT's 1.71% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KVUE Kenvue Inc. | 3.46% | 3.79% | 1.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABT Abbott Laboratories | 1.71% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
KVUE vs. ABT - Drawdown Comparison
The maximum KVUE drawdown since its inception was -33.22%, smaller than the maximum ABT drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for KVUE and ABT. For additional features, visit the drawdowns tool.
Volatility
KVUE vs. ABT - Volatility Comparison
Kenvue Inc. (KVUE) has a higher volatility of 9.02% compared to Abbott Laboratories (ABT) at 5.62%. This indicates that KVUE's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
KVUE vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Kenvue Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KVUE vs. ABT - Profitability Comparison
KVUE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Kenvue Inc. reported a gross profit of 2.07B and revenue of 3.66B. Therefore, the gross margin over that period was 56.5%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.
KVUE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Kenvue Inc. reported an operating income of 483.00M and revenue of 3.66B, resulting in an operating margin of 13.2%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.
KVUE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Kenvue Inc. reported a net income of 293.00M and revenue of 3.66B, resulting in a net margin of 8.0%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.